OPERATING AND REPORTABLE SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2015

(in thousands)



	Three Months Ended March 31,
	2015			2014
Results of Operations:
Revenue:
Infusion Services - product revenue	$	239,047		$	215,903
Infusion Services - service revenue	5,391			5,166
Total Infusion Services revenue	244,438			221,069
PBM Services - service revenue	17,243			18,224
Total revenue	$	261,681		$	239,293

Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	12,699		$	14,961
PBM Services	1,389			1,675
Total Segment Adjusted EBITDA	14,088			16,636

Corporate overhead	(7,768		)	(7,476		)

Interest expense, net	(9,163		)	(10,499		)
Income tax (expense) benefit	(1,928		)	(3,491		)
Depreciation	(4,304		)	(3,836		)
Amortization of intangibles	(1,490		)	(1,703		)
Stock-based compensation expense	(1,657		)	(2,886		)
Acquisition and integration expenses	(220		)	(6,499		)
Restructuring and other expenses and investments	(3,463		)	(5,502		)
Loss from continuing operations, net of income taxes	$	(15,905	)	$	(25,256	)



Supplemental Operating Data
	March 31, 2015		December 31, 2014
Total Assets:
Infusion Services	$	756,417	$	755,955
PBM Services	25,780		29,147
Corporate unallocated, including cash and cash equivalents	63,226		39,611
Total Assets	$	845,423	$	824,713

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details